Zydus Lifesciences Ltd. · ZYDUSLIFE
The daily read · from the close of 6 Oct
That day's whole fieldrank 539 of 856
Nifty in 10 sessions
In the middle of the field
+3.5% over 30 sessions · +11.5% vs Nifty over 90 · -0.6% vs its sector · 82% of its 52-week range. Layer percentiles across the field: L2 momentum 72.6, L3 vs market 82.2, L4 vs sector 44.7, L5 own record 45.2. The references are its own median ten-session rise and fall over the past year — arithmetic on its own history, not a price goal.
Its daily score over the last 60 sessions, oldest to newest; green when it sat in the top fifth, red in the bottom fifth. Of the 50 judged, 31 went the way its half of the field leaned.
How it has moved
All performers| Window | Move | vs Nifty | vs sector | vs itself | How it moved | Rank | |
|---|---|---|---|---|---|---|---|
| Week28 Sep on · 6 sessions | -3.7% | -2.1% | -2.0% | 9th pct | 2 of 6 up | 582 of 856 | |
| Month1 Sep on · 24 sessions | -0.2% | +5.3% | +2.2% | 47th pct | 13 of 24 up | 253 of 856 | |
| Quarter7 Jul on · 64 sessions | +1.0% | +7.8% | -1.6% | 48th pct | 31 of 64 up | 326 of 856 | |
| Half year7 Apr on · 125 sessions | +33.8% | +34.7% | +12.3% | 98th pct | 68 of 125 up | 240 of 855 | Stretched |
| Year7 Oct on · 246 sessions | +16.6% | +25.8% | -5.3% | 89th pct | 124 of 246 up | 255 of 855 |
The read
made on the morning of 16 May 2026 for Q4FY26Neutral — middle fifth of the companies reporting that week: rank 102 of 225, composite 53.1 out of 100. Moves 3.4% on results on average; rising broadly in line with the index, leads its sector.
A neutral read points neither way; this site tallies it as such in its track record.
How it went: went nowhere much +6.6% vs market over the ten sessions after 19 May 2026 — the post-mortem is further down.
A read is a position on a screen, not advice. The label says where the composite ranked, the tally says how often that has gone the way it pointed, and the choice is the reader's.
The read · morning of 16 May 2026
for Q4FY26 on 19 May 2026Moves 3.4% on results on average; rising broadly in line with the index, leads its sector.
Each layer is a percentile among this week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 34.6 + 0.20 × 65.7 + 0.30 × 41.1 + 0.20 × 86.4 = 53.1
Reactivity
Over the last 14 results the average absolute move from the session before the announcement to the session after was 3.4%. The largest was -9.6% (Q1FY25). Historically the pre-result 30-day trend reversed on the announcement in 78% of classified quarters.
- Typical move (T-1 → T+1)
- 3.4%
- Median move
- 2.6%
- Biggest
- -9.6% (Q1FY25)
- Up after 10 sessions
- 43% of 14
- Mean 10-session return
- +0.1%
- Mean 10-session vs market
- -0.3%
- Volume on result day
- 2.7× normal
- Pattern
- Reversal
Going in
Up 16.1% over 30 sessions and 12.2% over 90 sessions. Sitting at the 79th percentile of its 52-week range. Closed above its 20-day average on 73% of the last 30 sessions. Delivery volumes have been running 2.8 points lower than the 90-day average. A run-up of this size has historically been given back on this stock's announcement days.
Normally tracks NIFTY 50 at a correlation of 0.35; over the last 30 sessions that has run at 0.40 (-0.4 standard deviations from its own norm). Over 30 sessions it has outrun what its beta of 0.71 to the index would account for, by 11.9 percentage points. The move is broadly in line with the market's own direction.
Over 90 sessions it has outperformed NIFTY PHARMA by 2.9 percentage points, and led it over the last 30 by 5.3. Strength is showing against both the market and its own pack.
Where it sits
Beats market and sector over 90 sessions: +21.1% against the market, +2.9% against NIFTY PHARMA. Up and right is ahead of both; down and left is behind both.
Numbers behind the scores
- Share of reactions upward
- 64%
- Continuation ratio
- 22%
- Move spread (SD)
- 2.8%
- Average gap at open
- +0.63%
- 30-session return
- +16.1%
- 90-session return
- +12.2%
- Since last result
- +14.0% (62 sessions)
- 20-DMA vs 50-DMA
- +2.5%
- Sessions above 20-DMA
- 73%
- Position in 52-week range
- 79%
- Delivery, 30 / 90 sessions
- 42.7% / 45.5%
- Delivery trend
- -2.8 pp
- Benchmark
- NIFTY 50
- Correlation, 30 sessions / norm
- 0.40 / 0.35
- Correlation break
- -0.41 SD
- Beta, 30 / 90 sessions
- 0.61 / 0.81
- Alpha, 30 sessions
- +11.9%
- Market regime
- market tide
- Sector index
- NIFTY PHARMA
- vs sector, 30 / 90 sessions
- +5.3% / +2.9%
- Sector correlation / norm
- 0.75 / 0.63
- Quadrant score
- 100
- Evidence
- full · 14 results used
- Price band
- mid
What its results record says
16 results · ten sessions after each · from the close before the resultThis is the range each past result travelled, on closing prices. It is a description of the past, not a level for the next one, and this site gives no entry, exit or loss-limit levels.
Last 90 sessions
daily candles · adjusted for splits and bonuses · test patterns → · the outlook for the coming hours and days → · week by week: slope, patterns, next four weeks →Against the market and its sector
same 90 sessions · every line starts at 0%Around the last result · Q1FY27
ten sessions in, the result day, ten sessions out · from the close before the resultTen sessions after each result
share vs market vs sector · move from the close before the resultResults record
move from the close before each result| Quarter | Result day | Gap | T+1 | T+10 | Market T+10 | vs market | vs sector | Vol × | Result |
|---|---|---|---|---|---|---|---|---|---|
| Q1FY27 | 12 Aug 2026 | -0.1% | -2.0% | -3.4% | -1.1% | -2.4% | -3.0% | 3.4 | Rev 22% · PAT -35% YoY |
| Q4FY26 | 20 May 2026 | +4.6% | +1.7% | +5.7% | -0.9% | +6.6% | +8.8% | 10.1 | Rev 16% · PAT 8% YoY |
| Q3FY26 | 10 Feb 2026 | -0.4% | -2.7% | -2.1% | -1.7% | -0.4% | -3.7% | 3.4 | Rev 30% · PAT 0% YoY |
| Q2FY26 | 7 Nov 2025 | +0.2% | +1.2% | -1.3% | +2.2% | -3.5% | -2.8% | 0.8 | Rev 17% · PAT 35% YoY |
| Q1FY26 | 13 Aug 2025 | +0.0% | +3.5% | +2.7% | -0.2% | +2.9% | +2.4% | 2.3 | Rev 6% · PAT 3% YoY |
| Q4FY25 | 21 May 2025 | -0.5% | +2.3% | +5.5% | -0.3% | +5.7% | +5.9% | 1.6 | Rev 18% · PAT 0% YoY |
| Q3FY25 | 6 Feb 2025 | +0.7% | +1.8% | -7.9% | -3.3% | -4.6% | -3.0% | 4.9 | — |
| Q2FY25 | 13 Nov 2024 | +0.9% | +0.8% | -0.1% | +0.1% | -0.2% | +1.8% | 1.7 | — |
| Q1FY25 | 12 Aug 2024 | -0.2% | -9.6% | -14.3% | +2.7% | -17.0% | -16.7% | 1.6 | — |
| Q4FY24 | 21 May 2024 | +6.6% | +2.8% | -4.5% | -2.6% | -2.0% | -2.6% | 2.7 | — |
| Q3FY24 | 12 Feb 2024 | +0.6% | +6.6% | +17.1% | +1.6% | +15.5% | +15.3% | 5.4 | Rev 3% · PAT 25% YoY |
| Q2FY24 | 8 Nov 2023 | +0.7% | +2.5% | +5.7% | +2.0% | +3.7% | +2.2% | 4.5 | Rev 6% · PAT 53% YoY |
| Q1FY24 | 11 Aug 2023 | +0.6% | -2.5% | -3.6% | -1.2% | -2.4% | -0.9% | 3.0 | — |
| Q4FY23 | 19 May 2023 | +0.6% | -0.4% | +2.0% | +2.2% | -0.3% | -3.4% | 3.5 | — |
| Q3FY23 | 3 Feb 2023 | +0.3% | +8.6% | +8.7% | +1.9% | +6.8% | +10.0% | 1.2 | — |
| Q2FY23 | 14 Nov 2022 | -1.3% | -3.0% | -6.9% | +1.2% | -8.0% | -6.7% | 0.9 | — |
Reported figures
₹ crore; from the exchange's XBRL filings| Quarter | Period end | Revenue | YoY | PAT | YoY | Op. margin | EPS |
|---|---|---|---|---|---|---|---|
| Q1FY27 | 30 Jun 2026 | 8,017 | +22.0% | 990 | -34.9% | 23.8% | 9.35 |
| Q4FY26 | 31 Mar 2026 | 7,587 | +16.2% | 1,341 | +7.8% | 28.4% | 12.65 |
| Q3FY26 | 31 Dec 2025 | 6,864 | +30.3% | 1,022 | -0.3% | 25.2% | 10.36 |
| Q2FY26 | 30 Sep 2025 | 6,123 | +16.9% | 1,238 | +34.6% | 32.4% | 12.51 |
| Q1FY26 | 30 Jun 2025 | 6,573 | +5.9% | 1,521 | +2.6% | 31.8% | 14.58 |
| Q4FY25 | 31 Mar 2025 | 6,527 | +18.0% | 1,243 | -0.2% | 29.2% | 11.64 |
| Q3FY25 | 31 Dec 2024 | 5,269 | — | 1,026 | — | 26.3% | 10.17 |
| Q2FY25 | 30 Sep 2024 | 5,237 | — | 920 | — | 27.9% | 9.06 |
| Q1FY25 | 30 Jun 2024 | 6,207 | — | 1,482 | — | 33.6% | 14.11 |
| Q4FY24 | 31 Mar 2024 | 5,533 | — | 1,246 | — | 29.5% | 11.69 |
| Q3FY24 | 31 Dec 2023 | 4,505 | +3.3% | 789 | +25.1% | 24.5% | 7.80 |
| Q2FY24 | 30 Sep 2023 | 4,368 | +5.7% | 803 | +52.7% | 26.2% | 7.91 |
Post-mortems
Every result in full →- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- 4 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- Ran up 18% in the 30 sessions before the result — a good number had little left to reward.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- Volume ran 2.7x its prior month in the fortnight before.
- Its usual reversal pattern did not hold this quarter.
- 4 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 8 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Its reversal habit held this quarter.
- 11 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Its reversal habit held this quarter.
- 3 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 5 sector peers reported the same week; the sector read may already have been set.
- The market itself moved -3.3% over the same ten sessions; the raw move is mostly tide.
- Its sector moved -5.0% over the window.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 6 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 4 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- Ran up 23% in the 30 sessions before the result — a good number had little left to reward.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- 5 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- No read was made before this result; recorded for the base rate.
- Ran up 17% in the 30 sessions before the result — a good number had little left to reward.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- 3 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 8 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.